{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:53:04Z","timestamp":1791078784881,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["bprch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Haematology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.beha.2013.04.001","type":"journal-article","created":{"date-parts":[[2013,5,23]],"date-time":"2013-05-23T11:04:57Z","timestamp":1369307097000},"page":"3-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Biology and treatment of HTLV-1 associated T-cell lymphomas"],"prefix":"10.1016","volume":"26","author":[{"given":"Kunihiro","family":"Tsukasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensei","family":"Tobinai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2013.04.001_bib1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V50.3.481.481","article-title":"Adult T-cell leukemia: clinical and hematologic features of 16 cases","volume":"50","author":"Uchiyama","year":"1977","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.04.001_bib2","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","article-title":"Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma","volume":"77","author":"Poiesz","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.beha.2013.04.001_bib3","doi-asserted-by":"crossref","first-page":"6476","DOI":"10.1073\/pnas.78.10.6476","article-title":"Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera","volume":"78","author":"Hinuma","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5843","key":"10.1016\/j.beha.2013.04.001_bib4","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/294770a0","article-title":"Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells","volume":"294","author":"Miyoshi","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.beha.2013.04.001_bib5","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1073\/pnas.79.6.2031","article-title":"Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease","volume":"79","author":"Yoshida","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8452","key":"10.1016\/j.beha.2013.04.001_bib6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","article-title":"Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis","volume":"2","author":"Gessain","year":"1985","journal-title":"Lancet"},{"issue":"8488","key":"10.1016\/j.beha.2013.04.001_bib7","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","article-title":"HTLV-I associated myelopathy, a new clinical entity","volume":"1","author":"Osame","year":"1986","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.beha.2013.04.001_bib8","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1349-7006.1992.tb00092.x","article-title":"HTLV-I uveitis: a distinct clinical entity caused by HTLV-I","volume":"83","author":"Mochizuki","year":"1992","journal-title":"Jpn J Cancer Res"},{"issue":"8727","key":"10.1016\/j.beha.2013.04.001_bib9","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/0140-6736(90)92896-P","article-title":"Infective dermatitis of Jamaican children: a marker for HTLV-I infection","volume":"336","author":"LaGrenade","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.beha.2013.04.001_bib10","series-title":"Adult T-cell leukemia","author":"Takatsuki","year":"1994"},{"key":"10.1016\/j.beha.2013.04.001_bib11","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma: a report from the Lymphoma Study Group (1984\u201387)","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2013.04.001_bib12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/ijc.2910450206","article-title":"The 4th nationwide study of adult T-cell leukemia\/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features","volume":"45","author":"Tajima","year":"1990","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.beha.2013.04.001_bib13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/jmv.23181","article-title":"Current prevalence of HTLV-1 in Japan as determined by screening of blood donors","volume":"84","author":"Satake","year":"2012","journal-title":"J Med Virol"},{"issue":"10","key":"10.1016\/j.beha.2013.04.001_bib14","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1182\/blood.V92.10.3557","article-title":"Risk factors for adult T-cell leukemia among carriers of human T-lymphotropic virus type I","volume":"92","author":"Hisada","year":"1998","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.beha.2013.04.001_bib15","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood-2009-12-257410","article-title":"Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan","volume":"116","author":"Iwanaga","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.04.001_bib16","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1073\/pnas.0507631103","article-title":"HTLV-1 basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells","volume":"103","author":"Satou","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beha.2013.04.001_bib17","first-page":"3625","article-title":"Clinical significance of CCR4 expression in adult T-cell leukemia\/lymphoma: its close association with skin involvement and unfavorable outcome","volume":"9","author":"Ishida","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.beha.2013.04.001_bib18","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood.V89.3.948","article-title":"Integration patterns of HTLV-1 provirus in relation to the clinical course of ATL: frequent clonal change at crisis from indolent disease","volume":"89","author":"Tsukasaki","year":"1997","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.beha.2013.04.001_bib19","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1128\/JVI.69.5.2863-2868.1995","article-title":"Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy","volume":"69","author":"Wattel","year":"1995","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.beha.2013.04.001_bib20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ccr.2011.12.015","article-title":"Polycomb-mediated loss of miR-31 activates NIK-dependent NF-\u03baB pathway in adult T cell leukemia and other cancers","volume":"21","author":"Yamagishi","year":"2012","journal-title":"Cancer Cell."},{"issue":"1","key":"10.1016\/j.beha.2013.04.001_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-4608(98)00141-1","article-title":"High rate of chromosomal abnormalities in HTLV-I-infected T-cell colonies derived from prodromal phase of adult T-cell leukemia: a study of IL-2-stimulated colony formation in methylcellulose","volume":"109","author":"Fujimoto","year":"1999","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.beha.2013.04.001_bib22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.canlet.2005.03.039","article-title":"Impact of p53 aberration on the progression of adult T-cell leukemia\/lymphoma","volume":"234","author":"Tawara","year":"2006","journal-title":"Cancer Lett"},{"issue":"12","key":"10.1016\/j.beha.2013.04.001_bib23","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1182\/blood.V97.12.3875","article-title":"Comparative genomic hybridization analysis in adult T-cell leukemia\/lymphoma: correlation with clinical course","volume":"97","author":"Tsukasaki","year":"2001","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.beha.2013.04.001_bib24","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/sj.onc.1209898","article-title":"A genomic analysis of adult T-cell leukemia","volume":"26","author":"Choi","year":"2007","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.beha.2013.04.001_bib25","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1182\/blood-2004-03-1222","article-title":"Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia","volume":"105","author":"Sasaki","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.04.001_bib26","series-title":"WHO classification of tumour of haemaopoietic and lymphoid tissues","first-page":"281","article-title":"Adult T-cell leukemia\/lymphoma","author":"Ohshima","year":"2008"},{"key":"10.1016\/j.beha.2013.04.001_bib27","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1309\/2YGD1P0QCVCWBLDX","article-title":"Adult T-cell leukemia\/lymphoma in Bahia, Brazil: analysis of prognostic factors in a group of 70 patients","volume":"128","author":"Bittencourt","year":"2007","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.beha.2013.04.001_bib28","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1346-8138.2008.00465.x","article-title":"New entity, definition and diagnostic criteria of cutaneous adult T-cell leukemia\/lymphoma: human T-lymphotropic virus type 1 proviral DNA load can distinguish between cutaneous and smoldering types","volume":"35","author":"Amano","year":"2008","journal-title":"J Dermatol"},{"issue":"15","key":"10.1016\/j.beha.2013.04.001_bib29","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1182\/blood-2010-11-316794","article-title":"Type of skin eruption is an independent prognostic indicator for adult T-cell leukemia\/lymphoma","volume":"117","author":"Sawada","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.beha.2013.04.001_bib30","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1084\/jem.172.3.759","article-title":"Constitutive expression of parathyroid hormone-related protein gene in human T cell leukemia virus type 1 (HTLV-1) carriers and adult T cell leukemia patients that can be trans-activated by HTLV-1 tax gene","volume":"172","author":"Watanabe","year":"1990","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.beha.2013.04.001_bib31","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1182\/blood.V99.2.634","article-title":"Mechanism of hypercalcemia in adult T-cell leukemia: overexpression of receptor activator of nuclear factor kappaB ligand on adult T-cell leukemia cells","volume":"99","author":"Nosaka","year":"2002","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.beha.2013.04.001_bib32","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1182\/blood.V82.7.2017.2017","article-title":"Clinical course of human T-lymphotropic virus type I carriers with molecularly detectable monoclonal proliferation of T lymphocytes: defining a low- and high-risk population","volume":"82","author":"Ikeda","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.04.001_bib33","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1200\/JCO.2008.18.2428","article-title":"Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting","volume":"27","author":"Tsukasaki","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2013.04.001_bib34","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0145-2126(91)90087-A","article-title":"Major prognostic factors of patients with adult T-cell leukemia-lymphoma: a cooperative study","volume":"15","author":"Lymphoma Study Group","year":"1991","journal-title":"Leuk Res"},{"key":"10.1016\/j.beha.2013.04.001_bib35","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1200\/JCO.2011.38.2101","article-title":"Prognostic index for acute- and lymphoma-type adult T-cell leukemia\/lymphoma","volume":"30","author":"Katsuya","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2013.04.001_bib36","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1182\/blood.V118.21.881.881","article-title":"Characterization of long term survivors and a predictive model for aggressive adult T-cell leukemia-lymphoma (ATL): an ancillary study by the Japan Clinical Oncology Group, JCOG0902A","volume":"118","author":"Fukushima","year":"2011","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.beha.2013.04.001_bib37","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1182\/blood-2009-09-242347","article-title":"Long-term study of indolent adult T-cell leukemia-lymphoma","volume":"115","author":"Takasaki","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.04.001_bib38","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/BF02983215","article-title":"Deoxycoformycin-containing combination chemotherapy for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group study (JCOG9109)","volume":"77","author":"Tsukasaki","year":"2003","journal-title":"Int J Hematol"},{"key":"10.1016\/j.beha.2013.04.001_bib39","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1365-2141.2001.02737.x","article-title":"A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukemia-lymphoma (ATL): Japan Clinical Oncology Group (JCOG) Study 9303","volume":"113","author":"Yamada","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2013.04.001_bib40","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1200\/JCO.2007.11.9958","article-title":"VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801","volume":"25","author":"Tsukasaki","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2013.04.001_bib41","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1056\/NEJM199506293322603","article-title":"Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine","volume":"332","author":"Gill","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2013.04.001_bib42","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJM199506293322604","article-title":"Treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa","volume":"332","author":"Hermine","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2013.04.001_bib43","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1056\/NEJM199511093331911","article-title":"Interferon alfa and zidovudine in adult T-cell leukemia-lymphoma (correspondence)","volume":"333","author":"Tobinai","year":"1995","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.beha.2013.04.001_bib44","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1182\/blood-2006-01-0067","article-title":"Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence","volume":"108","author":"Datta","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.04.001_bib45","first-page":"417","article-title":"Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia\/lymphoma showing improved survival in the leukemic subtypes","volume":"27","author":"Bazarbachi","year":"2010","journal-title":"J Clin Oncol"},{"issue":"35","key":"10.1016\/j.beha.2013.04.001_bib46","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1200\/JCO.2011.35.5578","article-title":"Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia\/lymphoma","volume":"29","author":"Hodson","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2013.04.001_bib47","doi-asserted-by":"crossref","first-page":"6528","DOI":"10.1182\/blood-2009-03-211821","article-title":"Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia\/lymphoma (ATL)","volume":"113","author":"Kchour","year":"2009","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.beha.2013.04.001_bib48","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1182\/blood-2009-10-247510","article-title":"Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study","volume":"116","author":"Hishizawa","year":"2010","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.beha.2013.04.001_bib49","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1182\/blood-2011-07-368233","article-title":"Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study","volume":"119","author":"Kanda","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.04.001_bib50","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1182\/blood-2004-11-4193","article-title":"Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia\/lymphoma","volume":"105","author":"Okamura","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.beha.2013.04.001_bib51","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/bmt.2010.92","article-title":"Long-term outcomes after hematopoietic SCT for adult T-cell leukemia\/lymphoma: results of prospective trials","volume":"46","author":"Choi","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.beha.2013.04.001_bib52","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1182\/blood-2012-03-414490","article-title":"Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study","volume":"120","author":"Ishida","year":"2012","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.beha.2013.04.001_bib53","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1056\/NEJMc053295","article-title":"Donor-derived T-cell leukemia after bone marrow transplantation","volume":"354","author":"Tamaki","year":"2006","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.beha.2013.04.001_bib54","first-page":"619","article-title":"Phase I clinical study of SH L573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia and adult T-cell leukemia\/lymphoma","volume":"26","author":"Arima","year":"1999","journal-title":"Gan To Kagaku Ryoho"},{"issue":"5","key":"10.1016\/j.beha.2013.04.001_bib55","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/BF02986621","article-title":"Phase II study of cladribine (2-chlorodeoxyadenosine) in relapsed or refractory adult T-cell leukemia-lymphoma","volume":"77","author":"Tobinai","year":"2003","journal-title":"Int J Hematol"},{"issue":"4","key":"10.1016\/j.beha.2013.04.001_bib56","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/leu.2010.315","article-title":"LBH589, a deacetylase inhibitor, induces apoptosis in adult T-cell leukemia\/lymphoma cells via activation of a novel RAIDD-caspase-2 pathway","volume":"25","author":"Hasegawa","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2013.04.001_bib57","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/jnci\/81.12.914","article-title":"Multichain interleukin-2 receptor: a target for immunotherapy in lymphoma","volume":"81","author":"Waldmann","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.beha.2013.04.001_bib58","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1182\/blood.V86.11.4063.bloodjournal86114063","article-title":"Radioimmunotherapy of interleukin-2Ra-expressing adult T-cell leukemia with yttrium-90-labeled anti-Tac","volume":"86","author":"Waldmann","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.04.001_bib59","doi-asserted-by":"crossref","first-page":"7s","DOI":"10.1200\/jco.2010.28.15_suppl.8043","article-title":"Phase II trial of daclizumab in human T-cell lymphotropic virus type-1 (HTLV-1)-associated adult T-cell leukemia\/lymphoma (ATL)","volume":"28","author":"Berkowitz","year":"2010","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.beha.2013.04.001_bib60","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1158\/1078-0432.CCR-08-1254","article-title":"EBV-related lymphoproliferative disease complicating therapy with the anti-CD2 monoclonal antibody, siplizumab, in patients with T-cell malignancies","volume":"15","author":"O'Mahony","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.beha.2013.04.001_bib61","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1200\/JCO.2009.25.3575","article-title":"Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma","volume":"28","author":"Yamamoto","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2013.04.001_bib62","doi-asserted-by":"crossref","first-page":"128a","DOI":"10.1182\/blood.V116.21.285.285","article-title":"Multicenter phase II study of KW-0761, a defucosylated anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma (ATL)","volume":"116","author":"Ishida","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.04.001_bib63","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1182\/blood.V120.21.2737.2737","article-title":"Multicenter phase 1 dose-escalation study of lenalidomide (CC-5013) in relapsed patients with advanced adult T-cell leukemia-lymphoma or peripheral T-cell lymphoma","volume":"120","author":"Uike","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.04.001_bib64","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/sj.leu.2403400","article-title":"Proteasome inhibitor, bortezomib, potently inhibits the growth of adult T-cell leukemia cells both in\u00a0vivo and in\u00a0vitro","volume":"18","author":"Satou","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2013.04.001_bib65","first-page":"261","article-title":"PROPEL: a multi-center phase 2 open-label study of pralatrexate (PDX) with vitamin B12 and folic acid supplementation in patients with replapsed or refractory peripheral T-cell lymphoma","volume":"112","author":"O'Connor","year":"2008","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"issue":"25","key":"10.1016\/j.beha.2013.04.001_bib66","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.1182\/blood-2009-03-210989","article-title":"Pralatrexate-induced tumor cell apoptosis in the epidermis of a patient with HTLV-1 adult T-cell lymphoma\/leukemia causing skin erosions","volume":"113","author":"Marneros","year":"2009","journal-title":"Blood"}],"container-title":["Best Practice & Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692613000029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692613000029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T01:56:20Z","timestamp":1595814980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692613000029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1521692613000029"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2013.04.001","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biology and treatment of HTLV-1 associated T-cell lymphomas","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2013.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}